Maha FDA asks drug controller authorities to stop use of drug after patient's death in Mumbai
A person died at Saifee Hospital in Mumbai due to suspected adverse drug reaction of the drug, said a senior official from FDA's Pune division on Wednesday.
The Maharashtra Food & Drug Administration (FDA) has asked all drug controller authorities in the country to stop the use of a particular batch of drug INJ OROFER FCM following the death of a patient at a Mumbai hospital.
A person died at Saifee Hospital in Mumbai due to suspected adverse drug reaction of the drug, said a senior official from FDA's Pune division on Wednesday.
Orofer FCM injection is used to treat iron deficiency anaemia.
Emcure Pharmaceuticals, the manufacturer, was asked to recall the particular batch of the drug, said S B Patil, Joint Commissioner (Drugs) FDA.
Adverse reaction to drug
The death of a person at Saifee Hospital was due to suspected adverse reaction of this drug, he said.
As per the company, there could be spurious drugs available in the market in the name of INJ OROFER and because of such spurious drug the suspected adverse reaction might have taken place, he said.
The company also told the FDA that spurious versions of one of its other drugs was already being sold in the market, he said.
"Mumbai FDA team is carrying out a probe in the matter," Patil said, adding that samples from the batch of the drug have been collected from the distributors and sent for analysis.
RECENT STORIES
-
Daily Horoscope for Wednesday, October 16, 2024, for all zodiac signs by astrologer Vinayak Vishwas... -
Maharashtra Assembly Elections 2024: Fierce Political Showdown Looms As Sharad Pawar Takes On Ajit... -
Maharashtra Assembly Elections 2024: Government Issues 244 Resolutions Hours Before Poll... -
Mumbai: BMC Appoints Project Management Consultant For Coastal Road Phase 2, Investing ₹559 Crore... -
Thane: 20-Year-Old Man Dies After Falling From Crowded Local Train Between Dombivli And Kopar...